Development of both type I–B and type II CRISPR/Cas genome editing systems in the cellulolytic bacterium Clostridium thermocellum

Julie E. Walker, Anthony A. Lanahan, Tianyong Zheng, Camilo Toruno, Lee R. Lynd, Jeffrey C. Cameron, Daniel G. Olson, Carrie A. Eckert

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Abstract

The robust lignocellulose-solubilizing activity of C. thermocellum makes it a top candidate for consolidated bioprocessing for biofuel production. Genetic techniques for C. thermocellum have lagged behind model organisms thus limiting attempts to improve biofuel production. To improve our ability to engineer C. thermocellum, we characterized a native Type I–B and heterologous Type II Clustered Regularly-Interspaced Short Palindromic Repeat (CRISPR)/cas (CRISPR associated) systems. We repurposed the native Type I–B system for genome editing. We tested three thermophilic Cas9 variants (Type II) and found that GeoCas9, isolated from Geobacillus stearothermophilus, is active in C. thermocellum. We employed CRISPR-mediated homology directed repair to introduce a nonsense mutation into pyrF. For both editing systems, homologous recombination between the repair template and the genome appeared to be the limiting step. To overcome this limitation, we tested three novel thermophilic recombinases and demonstrated that exo/beta homologs, isolated from Acidithiobacillus caldus, are functional in C. thermocellum. For the Type I–B system an engineered strain, termed LL1586, yielded 40% genome editing efficiency at the pyrF locus and when recombineering machinery was expressed this increased to 71%. For the Type II GeoCas9 system, 12.5% genome editing efficiency was observed and when recombineering machinery was expressed, this increased to 94%. By combining the thermophilic CRISPR system (either Type I–B or Type II) with the recombinases, we developed a new tool that allows for efficient CRISPR editing. We are now poised to enable CRISPR technologies to better engineer C. thermocellum for both increased lignocellulose degradation and biofuel production.

Original languageEnglish
Article numbere00116
JournalMetabolic Engineering Communications
Volume10
DOIs
StatePublished - Jun 2020

Funding

We thank Timothy Chapman for this assistance characterizing the promoter insertion strains. We thank Michael Pyne for his assistance identifying Type I–B PAM sequences by BLAST search. We thank Adam Guss for his insightful discussions and technical advice. We thank Emily Freed for her critical reading of the manuscript and insightful discussions. We thank Yanhao Jiang for his assistance in molecular cloning for the Type II constructs. We would also like to thank members of the Cameron Lab, Lynd Lab, and Gill Lab for their support. This work was supported by the Center for Bioenergy Innovation . The Center for Bioenergy Innovation is a U.S. Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science . Genome resequencing was performed by the Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, and is supported by the Office of Science of the U.S. Department of Energy under contract number DE-AC02–05CH11231 .

FundersFunder number
Department of Energy Joint Genome Institute
U.S. Department of Energy Bioenergy Research Center
U.S. Department of EnergyDE-AC02–05CH11231
Office of Science
Biological and Environmental Research
Center for Bioenergy Innovation

    Keywords

    • CRISPR
    • Cas9
    • Clostridium thermocellum
    • Thermophilic recombineering
    • Type I–B

    Fingerprint

    Dive into the research topics of 'Development of both type I–B and type II CRISPR/Cas genome editing systems in the cellulolytic bacterium Clostridium thermocellum'. Together they form a unique fingerprint.

    Cite this